97 related articles for article (PubMed ID: 25564572)
21. Cytokines and Chemokines in HBV Infection.
Zhong S; Zhang T; Tang L; Li Y
Front Mol Biosci; 2021; 8():805625. PubMed ID: 34926586
[TBL] [Abstract][Full Text] [Related]
22. Niche Laminin and IGF-1 Additively Coordinate the Maintenance of Oct-4 Through CD49f/IGF-1R-Hif-2α Feedforward Loop in Mouse Germline Stem Cells.
Au HK; Peng SW; Guo CL; Lin CC; Wang YL; Kuo YC; Law TY; Ho HN; Ling TY; Huang YH
Front Cell Dev Biol; 2021; 9():646644. PubMed ID: 34381769
[TBL] [Abstract][Full Text] [Related]
23. A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
Ngo MT; Peng SW; Kuo YC; Lin CY; Wu MH; Chuang CH; Kao CX; Jeng HY; Lin GW; Ling TY; Chang TS; Huang YH
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359714
[TBL] [Abstract][Full Text] [Related]
24. PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance.
Yoon C; Lu J; Ryeom SW; Simon MC; Yoon SS
Cell Death Dis; 2021 Jul; 12(8):749. PubMed ID: 34321458
[TBL] [Abstract][Full Text] [Related]
25. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance.
Ngo MT; Jeng HY; Kuo YC; Diony Nanda J; Brahmadhi A; Ling TY; Chang TS; Huang YH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669204
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
27. Niche Modulation of IGF-1R Signaling: Its Role in Stem Cell Pluripotency, Cancer Reprogramming, and Therapeutic Applications.
Chen PC; Kuo YC; Chuong CM; Huang YH
Front Cell Dev Biol; 2020; 8():625943. PubMed ID: 33511137
[TBL] [Abstract][Full Text] [Related]
28. IL‑6 plays a crucial role in epithelial‑mesenchymal transition and pro‑metastasis induced by sorafenib in liver cancer.
Zhang KW; Wang D; Cai H; Cao MQ; Zhang YY; Zhuang PY; Shen J
Oncol Rep; 2021 Mar; 45(3):1105-1117. PubMed ID: 33432366
[TBL] [Abstract][Full Text] [Related]
29. COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
Francescangeli F; De Angelis ML; Baiocchi M; Rossi R; Biffoni M; Zeuner A
Front Oncol; 2020; 10():592891. PubMed ID: 33194755
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
He D; Zhang X; Tu J
Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
[TBL] [Abstract][Full Text] [Related]
31. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
32. Glycochenodeoxycholic acid induces stemness and chemoresistance via the STAT3 signaling pathway in hepatocellular carcinoma cells.
Shi C; Yang J; Hu L; Liao B; Qiao L; Shen W; Xie F; Zhu G
Aging (Albany NY); 2020 Aug; 12(15):15546-15555. PubMed ID: 32756004
[TBL] [Abstract][Full Text] [Related]
33. Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.
Tang J; Sui CJ; Wang DF; Lu XY; Luo GJ; Zhao Q; Lian QY; Jeong S; Lin XM; Zhu YJ; Zheng B; Wu R; Wang Q; Liu XL; Liu JF; Xia Q; Wu G; Gu J; Wang HY; Chen L
Theranostics; 2020; 10(12):5384-5397. PubMed ID: 32373219
[No Abstract] [Full Text] [Related]
34. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
35. BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming.
Chen YY; Wang WH; Che L; Lan Y; Zhang LY; Zhan DL; Huang ZY; Lin ZN; Lin YC
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32168902
[TBL] [Abstract][Full Text] [Related]
36. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.
Ye C; Zhang X; Chen X; Cao Q; Zhang X; Zhou Y; Li W; Hong L; Xie H; Liu X; Cao H; Wang YJ; Kang B
Cell Oncol (Dordr); 2020 Apr; 43(2):279-295. PubMed ID: 31848930
[TBL] [Abstract][Full Text] [Related]
37. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
38. Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Lee KL; Kuo YC; Ho YS; Huang YH
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31505803
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
40. Homeobox Genes and Hepatocellular Carcinoma.
Liu KY; Wang LT; Hsu SH; Wang SN
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31058850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
